Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma 1Primary Myelofibrosis 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Leukemia, Myeloid, Acute 1Leukemia, Myeloid 1Breast Neoplasms 1

Interventions

Doxorubicin 13Specimen Handling 12pembrolizumab 11Magnetic Resonance Spectroscopy 10Biopsy 10Cyclophosphamide 9X-Rays 7Ifosfamide 7Radiotherapy 6Phantoms, Imaging 6Gemcitabine 6liposomal doxorubicin 5Nivolumab 5tazemetostat 4palbociclib 4fludarabine 4atezolizumab 4Temozolomide 4Radiation 4Nuclear Medicine Department, Hospital 4Irinotecan 4larotrectinib 3cabozantinib 3Surveys and Questionnaires 3Ipilimumab 3Carboplatin 3Bevacizumab 3ulixertinib 2tipifarnib 2selpercatinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcoma × Hyperbaric Oxygenation × 90 days × Clear all
NCT03144206 2026-03-27

Hyperbaric Oxygen Therapy for Soft Tissue Sarcoma Pilot Study

Duke University

Phase 4 Active not recruiting
20 enrolled
Sarcoma

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡